mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.1 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.1 |